Skip to main content
OpenTrials
Completed

NCT Number: NCT04045561

Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure

The hypothesis is that the implementation of an initial Pharmaceutical Consultation (PC) program based on the provision of standardized information to patients treated for multiple myeloma as a first course of chemotherapy, could optimize their compliance with the delivered per os treatment.

The aim of this study is therefore to develop a standardised reference guide of information to be provided during prostate cancer in order to optimise the compliance of patients treated for multiple myeloma as a first course of chemotherapy per os.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Myeloma Blood Protein Disorders Cardiovascular Diseases Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhagic Disorders Hemostatic Disorders Immune System Diseases Immunoproliferative Disorders Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Neoplasms, Plasma Cell Paraproteinemias Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Nîmes

Nîmes, Gard, 30029, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 18 years old
  • The patient is treated for multiple myeloma, is naive to any treatment and begins a chemotherapy protocol with oral therapy and whose course of care includes a stay in the Day Hospital or retrocessions.

Criteria for non-inclusion

  • The subject is participating in another study
  • The subject is in an exclusion period determined by a previous study
  • The subject is under the protection of justice, guardianship or curatorship
  • It is impossible to give informed information about
  • The patient is pregnant, parturient, or breastfeeding
  • The patient receives a follow-up by a home nurse for the administration of oral medication
  • The patient is treated only with oral chemotherapy in the city
  • The patient has early dementia.

Translated with www.DeepL.com/Translator

-

Treatment and study plan

Primary outcomes

  1. evaluating the understanding

    Time frame: Day 1

    Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution.

  2. evaluating understanding

    Time frame: Day 1

    Questionnaire. qualitative variables: measurement of their number and

  3. evaluating the quality of information

    Time frame: Day 1

    Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution.

  4. evaluating quality of information

    Time frame: Day 1

    Questionnaire. qualitative variables: measurement of their number and percentage.

Secondary outcomes

  1. The time required for the pharmaceutical consultation

    Time frame: Day 1

    minutes

  2. satisfaction des patients

    Time frame: Day 1

    by an Analogue Visual Scale (0-10-very satisfied)

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Official study title

Elaboration of a Standardized Referential Guide of the Information to Optimize the Adherence to be Given During an Initial Pharmaceutical Consultation (CP) to the Patient Suffering From Multiple Myeloma in Primocure Chemotherapy Per os

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Aug 5, 2019
Registry last updated
Jun 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.